These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 21658763)
1. Well-defined, reversible disulfide cross-linked micelles for on-demand paclitaxel delivery. Li Y; Xiao K; Luo J; Xiao W; Lee JS; Gonik AM; Kato J; Dong TA; Lam KS Biomaterials; 2011 Sep; 32(27):6633-45. PubMed ID: 21658763 [TBL] [Abstract][Full Text] [Related]
2. Disulfide cross-linked micelles of novel HDAC inhibitor thailandepsin A for the treatment of breast cancer. Xiao K; Li YP; Wang C; Ahmad S; Vu M; Kuma K; Cheng YQ; Lam KS Biomaterials; 2015 Oct; 67():183-93. PubMed ID: 26218744 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
4. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel. Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162 [TBL] [Abstract][Full Text] [Related]
5. LHRH-Targeted Redox-Responsive Crosslinked Micelles Impart Selective Drug Delivery and Effective Chemotherapy in Triple-Negative Breast Cancer. Xiao K; Liu Q; Suby N; Xiao W; Agrawal R; Vu M; Zhang H; Luo Y; Li Y; Lam KS Adv Healthc Mater; 2021 Feb; 10(3):e2001196. PubMed ID: 33200571 [TBL] [Abstract][Full Text] [Related]
6. A novel size-tunable nanocarrier system for targeted anticancer drug delivery. Li Y; Xiao K; Luo J; Lee J; Pan S; Lam KS J Control Release; 2010 Jun; 144(3):314-23. PubMed ID: 20211210 [TBL] [Abstract][Full Text] [Related]
7. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491 [TBL] [Abstract][Full Text] [Related]
8. A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles. Li Y; Bharadwaj G; Lee JS J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060268 [TBL] [Abstract][Full Text] [Related]
9. Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles. Shi Y; van der Meel R; Theek B; Oude Blenke E; Pieters EH; Fens MH; Ehling J; Schiffelers RM; Storm G; van Nostrum CF; Lammers T; Hennink WE ACS Nano; 2015; 9(4):3740-52. PubMed ID: 25831471 [TBL] [Abstract][Full Text] [Related]
10. Reversibly disulfide cross-linked micelles improve the pharmacokinetics and facilitate the targeted, on-demand delivery of doxorubicin in the treatment of B-cell lymphoma. Xiao K; Liu Q; Al Awwad N; Zhang H; Lai L; Luo Y; Lee JS; Li Y; Lam KS Nanoscale; 2018 May; 10(17):8207-8216. PubMed ID: 29682647 [TBL] [Abstract][Full Text] [Related]
11. Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links. Koo AN; Min KH; Lee HJ; Lee SU; Kim K; Kwon IC; Cho SH; Jeong SY; Lee SC Biomaterials; 2012 Feb; 33(5):1489-99. PubMed ID: 22130564 [TBL] [Abstract][Full Text] [Related]
12. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
13. Reduction-responsive crosslinked micellar nanoassemblies for tumor-targeted drug delivery. Fan W; Wang Y; Dai X; Shi L; Mckinley D; Tan C Pharm Res; 2015 Apr; 32(4):1325-40. PubMed ID: 25319102 [TBL] [Abstract][Full Text] [Related]
14. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123 [TBL] [Abstract][Full Text] [Related]
15. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel. Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196 [TBL] [Abstract][Full Text] [Related]
16. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
17. A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer. Xiao K; Luo J; Fowler WL; Li Y; Lee JS; Xing L; Cheng RH; Wang L; Lam KS Biomaterials; 2009 Oct; 30(30):6006-16. PubMed ID: 19660809 [TBL] [Abstract][Full Text] [Related]
18. Dual Receptor-Targeted and Redox-Sensitive Polymeric Micelles Self-Assembled from a Folic Acid-Hyaluronic Acid-SS-Vitamin E Succinate Polymer for Precise Cancer Therapy. Yang Y; Li Y; Chen K; Zhang L; Qiao S; Tan G; Chen F; Pan W Int J Nanomedicine; 2020; 15():2885-2902. PubMed ID: 32425522 [TBL] [Abstract][Full Text] [Related]
19. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
20. Extremely long tumor retention, multi-responsive boronate crosslinked micelles with superior therapeutic efficacy for ovarian cancer. Xiao W; Suby N; Xiao K; Lin TY; Al Awwad N; Lam KS; Li Y J Control Release; 2017 Oct; 264():169-179. PubMed ID: 28847739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]